FeesSafety
Pluang+

Lisaftoclax gains Breakthrough Therapy Designation in China for first-line CLL/SLL treatment

Market News
21 Oct 2026, 02:30 WIB
GlobeNewsWire
View Source
Bullish
Lisaftoclax gains Breakthrough Therapy Designation in China for first-line CLL/SLL treatment

Ascentage Pharma's lisaftoclax, combined with acalabrutinib, received Breakthrough Therapy Designation from China's NMPA for treating treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). This designation accelerates development and review, reflecting the urgent need for improved therapies in CLL/SLL, a cancer affecting mainly older adults with rising incidence in China. Lisaftoclax is already approved in China for previously treated CLL/SLL patients and is undergoing global Phase III trials for first-line use. This advancement may lead to faster patient access to this novel treatment option.

Ascentage Pharma’s lisaftoclax breakthrough therapy designation provides context for health sector activity. For readers following Health stocks, here is Pluang's market snapshot as of Oct 21, 2026 05:01 WIB: Out of 150 priced US Health stocks, 129 rose and 21 fell today. Among notable movers, AMWL rose 7.46% to USD 13.25 with a typical hold time of 62 days, contrasting with DYN and ERAS, which gained 7.29% and 7.27% respectively but have much shorter typical hold times of 2 days and 100% buy order activity on DYN and ERAS.

More News

Monday.com expands AI platform; Okta leads in identity security with strong 2026 results.

Monday.com expands AI platform; Okta leads in identity security with strong 2026 results.

Monday.com is growing its AI-driven platform beyond work management into CRM and software development, achieving 22.4% revenue growth and nearly $1.4 billion in revenue for the year ending September 2026. Okta, a leader in identity security, serves o...

Market News
Neutral
18 minutes ago
Invest long-term and avoid market timing to maximize returns, inspired by Wayne Gretzky's advice.

Invest long-term and avoid market timing to maximize returns, inspired by Wayne Gretzky's advice.

Warren Buffett highlights Wayne Gretzky's famous advice, "Skate to where the puck is going to be," as a key investing lesson: focus on the future and stay invested long-term. Fidelity research shows missing the five best days in the S&P 500 from 1987...

Market News
Bullish
36 minutes ago
New AI tool checks stock filings for hidden warning signs to aid investors' decisions.

New AI tool checks stock filings for hidden warning signs to aid investors' decisions.

A new AI-powered prompt helps investors identify warning signs in company filings by scanning for issues like auditor doubts, insider sales, and leadership changes. It highlights items worth closer inspection without giving investment advice, using r...

Market News
Bearish
36 minutes ago
Netflix's stock drops nearly 47% but remains profitable with growth potential over five years.

Netflix's stock drops nearly 47% but remains profitable with growth potential over five years.

Netflix's shares have fallen nearly 47% from their 52-week high, reflecting concerns about slowing revenue growth and increased competition. Despite this, Netflix remains highly profitable, with rising operating margins and expected revenue growth of...

Market News
Neutral
51 minutes ago
Tesla ends Cybertruck production, boosting Rivian's chance to capture electric truck buyers.

Tesla ends Cybertruck production, boosting Rivian's chance to capture electric truck buyers.

Tesla is ending production of its Cybertruck to focus on other projects, leading to increased demand for alternative electric trucks. Rivian, with its newly launched lower-cost R2 model, is well-positioned to attract former Cybertruck customers. This...

Market News
Bullish
59 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App